- Home
- HUMA vs ONDS Comparison
HUMA vs ONDS Comparison
Compare HUMA & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- ONDS
- Stock Information
- Founded
- HUMA 2004
- ONDS 2014
- Country
- HUMA United States
- ONDS United States
- Employees
- HUMA N/A
- ONDS N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- ONDS Telecommunications Equipment
- Sector
- HUMA Health Care
- ONDS Telecommunications
- Exchange
- HUMA Nasdaq
- ONDS Nasdaq
- Market Cap
- HUMA 367.6M
- ONDS 326.8M
- IPO Year
- HUMA N/A
- ONDS N/A
- Fundamental
- Price
- HUMA $2.34
- ONDS $2.13
- Analyst Decision
- HUMA Strong Buy
- ONDS Strong Buy
- Analyst Count
- HUMA 7
- ONDS 2
- Target Price
- HUMA $13.00
- ONDS $3.25
- AVG Volume (30 Days)
- HUMA 3.4M
- ONDS 20.8M
- Earning Date
- HUMA 08-12-2025
- ONDS 08-13-2025
- Dividend Yield
- HUMA N/A
- ONDS N/A
- EPS Growth
- HUMA N/A
- ONDS N/A
- EPS
- HUMA N/A
- ONDS N/A
- Revenue
- HUMA $517,000.00
- ONDS $10,815,867.00
- Revenue This Year
- HUMA N/A
- ONDS $243.35
- Revenue Next Year
- HUMA $896.45
- ONDS $118.81
- P/E Ratio
- HUMA N/A
- ONDS N/A
- Revenue Growth
- HUMA N/A
- ONDS N/A
- 52 Week Low
- HUMA $1.15
- ONDS $0.54
- 52 Week High
- HUMA $9.79
- ONDS $3.40
- Technical
- Relative Strength Index (RSI)
- HUMA 50.49
- ONDS 60.24
- Support Level
- HUMA $2.13
- ONDS $1.71
- Resistance Level
- HUMA $2.80
- ONDS $1.93
- Average True Range (ATR)
- HUMA 0.18
- ONDS 0.20
- MACD
- HUMA 0.01
- ONDS -0.02
- Stochastic Oscillator
- HUMA 35.69
- ONDS 51.08
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.